Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Ovarian Cancer
More than ever before, gynecologic surgeons, oncologists, and pathologists need to work together to assess treatment options for each patient.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • CCM clock hours
  • Participation
Navigating Treatment Selection for Patients with Advanced Ovarian Cancer
Multidisciplinary involvement, including nursing and palliative care specialists, is key to providing the best care possible for patients with recurrent/refractory ovarian cancer.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • ANCC contact hours
  • Participation
Use of PARP Inhibitors for Ovarian Cancer
The data on PARP inhibitors for treatment of ovarian, primary peritoneal, or fallopian tube cancers has led to substantial changes in the recommendations for molecular testing, maintenance after first-line therapy, recurrence therapy, and maintenance after recurrence therapy.
Category
  • Ovarian Cancer
Format
  • Recorded Webcast
Credits
  • AAPA Category 1 CME credit
  • ACPE contact hours
  • AMA PRA Category 1 Credit™
  • ANCC contact hours
  • Participation